发布文献求助

清晨好，您是今天最早来到科研通的研友！由于当前在线用户较少，发布求助请尽量完整地填写文献信息，科研通机器人24小时在线，伴您科研之路漫漫前行！

Venovenom

Lv1

30 积分 2024-11-17 加入

最近求助
最近应助
互助留言

Assessment of adverse effects of Alzheimer's disease medications: Analysis of notifications to Regional Pharmacovigilance Centers in Northwest France 4小时前 求助中
Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder 1个月前 已完结
Differential effects of rivastigmine, galantamine and donepezil on behavioral and psychological symptoms in patients with Alzheimer's disease: 18-month, randomized, open-label trial 1个月前 已完结
A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease 1个月前 已关闭
Late Phase II Clinical Study of Acetylcholinesterase Inhibitor E2020 in Patients with Alzheimer-type Dementia -24-48-weeks Double-blind, Placebo-Controlled Study- 1个月前 已关闭
A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease 3个月前 已关闭
A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease 3个月前 已关闭
▼Memantine for dementia? 3个月前 已关闭
Alzheimer’s disease and epilepsy: Research hotspots for comorbidity in the era of global aging 9个月前 已完结

没有进行任何应助

帮大忙了 9个月前

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

Copyright © 2020-2025 AbleSci.COM, 科研通, All Right Reserved

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：941272744【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通